Jane Street’s Co-Diagnostics CODX Stock Holding History

Jane Street’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,613	Closed	-$432K	–	10365
2021 Q4	$432K	Sell	1,613 -1,734	-52%	-$455K	﹤0.01%	7523
2021 Q3	$977K	Buy	3,347 +450	+16%	+$131K	﹤0.01%	5953
2021 Q2	$717K	Sell	2,897 -363	-11%	-$93.3K	﹤0.01%	6536
2021 Q1	$933K	Sell	3,260 -863	-21%	-$344K	﹤0.01%	5587
2020 Q4	$1.15M	Sell	4,123 -1,077	-21%	-$399K	﹤0.01%	4414
2020 Q3	$2.12M	Buy	5,200 +1,480	+40%	+$760K	﹤0.01%	2942
2020 Q2	$2.16M	Buy	+3,720	New	+$1.7M	﹤0.01%	2956

Other funds holding CODX

PAG

Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAM

Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HWA

Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Jane Street's CODX Position: Q1 2026 in Review

Jane Street sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 8,031 shares — an estimated $40.6K sold.

Jane Street first reported a position in CODX in Q1 2020 and held it in 17 quarters. The position peaked at $793K in Q3 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

Jane Street reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 8,031 Co-Diagnostics shares in Q1 2026, an estimated $40.6K.
Jane Street first reported a position in Co-Diagnostics in Q1 2020 and held it in 17 quarters.
Jane Street's Co-Diagnostics position peaked at $793K in Q3 2020.
14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.